From 26950.68$

lanadelumab-flyo

Hereditary angioedema agents

Scoring is done by our AI based assistant on the data from the FDA and other sources

7.4

10

Effectiveness

Safety

Addiction

Ease of Use

Contraindications

8.1

Ecallantide

7.5

Complement C1 esterase inhibitor

7.4

Takhzyro

7.4

Ruconest

7.4

Orladeyo

7.4

Berotralstat

7.4

Icatibant

7.1

Lanadelumab

6.7

Firazyr

6.7

Conestat alfa

6.7

Lanadelumab-flyo (Subcutaneous)

6.5

Berinert

6.1

Cinryze

5.6

Kalbitor

5.2

Haegarda